- call +1-201-465-4211
- email sales@mrinsights.biz
Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons.
Scope of the Report:
This report studies the Neuromodulation market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Neuromodulation market by product type and applications/end industries.
The key drivers for the growth of neuromodulation market include rise in geriatric population, their vulnerability for neurological disorders, increase in incidence of neurological diseases, such as Alzheimer’s and Parkinson’s diseases, and the increase in awareness regarding the safety and efficacy of neurostimulator devices. However, restrains, such as lack of trained healthcare professionals and stringent approval policies, are expected to hinder the market.
Spinal cord stimulation is the dominating segment whereas repetitive transcranial magnetic stimulation is the fastest growing segment among various neuromodulation technologies. Chronic pain management is the largest application segment and migraine is the fastest growing segment owing to the high incidence rate.
North America is the most attractive market in the global neuromodulation industry and is expected to be the first preference for new entrants due to the increasing end-use in the region. Asia-Pacific is the fastest growing market; hence the established players are focusing on the region.
The global Neuromodulation market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Neuromodulation.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Medtronic
Boston Scientific
Jude Medical
Synapse Biomedical
Nevro
Neurosigma
Neuropace
Neuronetics
Cyberonics
BioControl Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Deep Brain Stimulation
Spinal Cord Stimulation
Transcranial Magnetic Stimulation
Market Segment by Applications, can be divided into
Depression
Parkinson’s
Tinnitus
Alzheimer’s
Epilepsy
Ischemia
Obesity
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Neuromodulation Market Overview
1.1 Product Overview and Scope of Neuromodulation
1.2 Classification of Neuromodulation by Types
1.2.1 Global Neuromodulation Revenue Comparison by Types (2017-2023)
1.2.2 Global Neuromodulation Revenue Market Share by Types in 2017
1.2.3 Deep Brain Stimulation
1.2.4 Spinal Cord Stimulation
1.2.5 Transcranial Magnetic Stimulation
1.3 Global Neuromodulation Market by Application
1.3.1 Global Neuromodulation Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Depression
1.3.3 Parkinson’s
1.3.4 Tinnitus
1.3.5 Alzheimer’s
1.3.6 Epilepsy
1.3.7 Ischemia
1.3.8 Obesity
1.4 Global Neuromodulation Market by Regions
1.4.1 Global Neuromodulation Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Neuromodulation Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Neuromodulation Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Neuromodulation Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Neuromodulation Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Neuromodulation Status and Prospect (2013-2023)
1.5 Global Market Size of Neuromodulation (2013-2023)
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Business Overview
2.1.2 Neuromodulation Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Medtronic Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boston Scientific
2.2.1 Business Overview
2.2.2 Neuromodulation Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boston Scientific Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)
2.3 Jude Medical
2.3.1 Business Overview
2.3.2 Neuromodulation Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Jude Medical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)
2.4 Synapse Biomedical
2.4.1 Business Overview
2.4.2 Neuromodulation Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Synapse Biomedical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)
2.5 Nevro
2.5.1 Business Overview
2.5.2 Neuromodulation Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Nevro Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)
2.6 Neurosigma
2.6.1 Business Overview
2.6.2 Neuromodulation Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Neurosigma Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)
2.7 Neuropace
2.7.1 Business Overview
2.7.2 Neuromodulation Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Neuropace Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)
2.8 Neuronetics
2.8.1 Business Overview
2.8.2 Neuromodulation Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Neuronetics Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cyberonics
2.9.1 Business Overview
2.9.2 Neuromodulation Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cyberonics Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)
2.10 BioControl Medical
2.10.1 Business Overview
2.10.2 Neuromodulation Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 BioControl Medical Neuromodulation Revenue, Gross Margin and Market Share (2016-2017)
3 Global Neuromodulation Market Competition, by Players
3.1 Global Neuromodulation Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Neuromodulation Players Market Share
3.2.2 Top 10 Neuromodulation Players Market Share
3.3 Market Competition Trend
4 Global Neuromodulation Market Size by Regions
4.1 Global Neuromodulation Revenue and Market Share by Regions
4.2 North America Neuromodulation Revenue and Growth Rate (2013-2018)
4.3 Europe Neuromodulation Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Neuromodulation Revenue and Growth Rate (2013-2018)
4.5 South America Neuromodulation Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Neuromodulation Revenue and Growth Rate (2013-2018)
5 North America Neuromodulation Revenue by Countries
5.1 North America Neuromodulation Revenue by Countries (2013-2018)
5.2 USA Neuromodulation Revenue and Growth Rate (2013-2018)
5.3 Canada Neuromodulation Revenue and Growth Rate (2013-2018)
5.4 Mexico Neuromodulation Revenue and Growth Rate (2013-2018)
6 Europe Neuromodulation Revenue by Countries
6.1 Europe Neuromodulation Revenue by Countries (2013-2018)
6.2 Germany Neuromodulation Revenue and Growth Rate (2013-2018)
6.3 UK Neuromodulation Revenue and Growth Rate (2013-2018)
6.4 France Neuromodulation Revenue and Growth Rate (2013-2018)
6.5 Russia Neuromodulation Revenue and Growth Rate (2013-2018)
6.6 Italy Neuromodulation Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Neuromodulation Revenue by Countries
7.1 Asia-Pacific Neuromodulation Revenue by Countries (2013-2018)
7.2 China Neuromodulation Revenue and Growth Rate (2013-2018)
7.3 Japan Neuromodulation Revenue and Growth Rate (2013-2018)
7.4 Korea Neuromodulation Revenue and Growth Rate (2013-2018)
7.5 India Neuromodulation Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Neuromodulation Revenue and Growth Rate (2013-2018)
8 South America Neuromodulation Revenue by Countries
8.1 South America Neuromodulation Revenue by Countries (2013-2018)
8.2 Brazil Neuromodulation Revenue and Growth Rate (2013-2018)
8.3 Argentina Neuromodulation Revenue and Growth Rate (2013-2018)
8.4 Colombia Neuromodulation Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Neuromodulation by Countries
9.1 Middle East and Africa Neuromodulation Revenue by Countries (2013-2018)
9.2 Saudi Arabia Neuromodulation Revenue and Growth Rate (2013-2018)
9.3 UAE Neuromodulation Revenue and Growth Rate (2013-2018)
9.4 Egypt Neuromodulation Revenue and Growth Rate (2013-2018)
9.5 Nigeria Neuromodulation Revenue and Growth Rate (2013-2018)
9.6 South Africa Neuromodulation Revenue and Growth Rate (2013-2018)
10 Global Neuromodulation Market Segment by Type
10.1 Global Neuromodulation Revenue and Market Share by Type (2013-2018)
10.2 Global Neuromodulation Market Forecast by Type (2018-2023)
10.3 Deep Brain Stimulation Revenue Growth Rate (2013-2023)
10.4 Spinal Cord Stimulation Revenue Growth Rate (2013-2023)
10.5 Transcranial Magnetic Stimulation Revenue Growth Rate (2013-2023)
11 Global Neuromodulation Market Segment by Application
11.1 Global Neuromodulation Revenue Market Share by Application (2013-2018)
11.2 Neuromodulation Market Forecast by Application (2018-2023)
11.3 Depression Revenue Growth (2013-2018)
11.4 Parkinson’s Revenue Growth (2013-2018)
11.5 Tinnitus Revenue Growth (2013-2018)
11.6 Alzheimer’s Revenue Growth (2013-2018)
11.7 Epilepsy Revenue Growth (2013-2018)
11.8 Ischemia Revenue Growth (2013-2018)
11.9 Obesity Revenue Growth (2013-2018)
12 Global Neuromodulation Market Size Forecast (2018-2023)
12.1 Global Neuromodulation Market Size Forecast (2018-2023)
12.2 Global Neuromodulation Market Forecast by Regions (2018-2023)
12.3 North America Neuromodulation Revenue Market Forecast (2018-2023)
12.4 Europe Neuromodulation Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Neuromodulation Revenue Market Forecast (2018-2023)
12.6 South America Neuromodulation Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Neuromodulation Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Neuromodulation Picture
Table Product Specifications of Neuromodulation
Table Global Neuromodulation and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
